A carregar...
Discussion of Trial Designs for Biomarker Identification and Validation Through the Use of Case Studies
With the launch of the National Cancer Institute’s Precision Medicine Initiative in 2015, there has been a shift to trial designs that tailor health care solutions to individual patients by using a screening platform and by moving away from the one-trial/one-biomarker-at-a-time approach. To make pre...
Na minha lista:
| Publicado no: | JCO Precis Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Clinical Oncology
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7079723/ https://ncbi.nlm.nih.gov/pubmed/32190807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00051 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|